Pulsatile Perfusion Reduces the Risk of Delayed Graft Function in Deceased Donor Kidney Transplants, Irrespective of Donor Type and Cold Ischemic Time

In a 2013 publication, Gill et.al. sought to examine two things: the patterns of utilization of hypothermic machine perfusion (HMP) as a function of cold ischemic time (CIT) and donor type as well as the impact of HMP on the risk of DGF by CIT and donor type. They used data from the Scientific Registry of Transplant Recipients (SRTR) on all adult deceased donor kidney transplant recipients between January 1, 2000 and December 1, 2011 to complete their analysis.

The overall results of the analysis were:

  • In standard criteria donors (SCD)
    • The odds of DGF were lower with HMP compared to CS at all CIT
  • In extended criteria donors (ECD)
    • HMP use was associated with reduced risk of DGF when CIT is beyond 6 hours
  • In donation after circulatory death (DCD) donors
    • HMP use was associated with reduced risk of DGF when the CIT is between 6 and 24 hours

They summarized that their data confirmed the benefits of HMP use in reducing the risk of DGF irrespective of the donor type and CIT.  They concluded that the best strategy to reduce the risk of DGF if to use HMP and minimize CIT in all deceased donor kidney transplants.

Read the full article here: https://doi.org/10.1097/01.tp.0000438637.29214.10

Tagged In:

CIT, DCD, DGF, ECD, HMP, Kidney, SCD

The Latest

Check out the most recent posts

Katie, Strategic Account Manager

Katie, Strategic Account Manager

My connection to donation and transplantation began with my uncle’s heart transplant in 2002. Since 2011, I’ve served the field through roles in organ procurement, transplant nursing, service line leadership, and industry support for diagnostics and immunosuppressive...

Perspective: One Mission, Many Stories

Author: Virginia Liuti, Strategic Account Manager July 22, 2026As we approach World Organ Donation Day on August 13, I have been reflecting on my own journey in healthcare and how it has shaped the way I see our transplant community. Before joining Organ Recovery...

Ruthanne, Manager, Medical Affairs

Ruthanne, Manager, Medical Affairs

With nearly 30 years of experience in organ transplantation and donation, I joined ORS in April 2024. In my current role as Manager of Medical Affairs, I translate clinical insights into actionable guidance, ensure clear and credible scientific communication across...